The new guidelines, issued Monday by the American Heart Association and the federal government, were aimed at preventing heart attacks.The authors did not disclose their biases. These drugs cost up to $100 per month, so this paper could generate billions of dollars of drug revenue.
They were written by nine of the country's top cholesterol experts. At least six have received consulting or speaking fees, research money or other support from makers of the most widely used anti-cholesterol drugs.
The new guidelines would add about 7 million more Americans to the 36 million already encouraged to take the pills to lower their cholesterol, ...
A NJ paper says:
One panel member, NIH scientist Bryan Brewer, was chastised last week by Public Citizen, a watchdog group, for writing a favorable journal article about AstraZeneca's Crestor without disclosing that he received grants from the company. AstraZeneca has declined to discuss the nature of the grants or how much Brewer received. Brewer has declined to comment.After the criticism, the authors finally disclosed a summary of their financial biases. 8 out of the 9 were paid off by cholesterol drug companies.
No comments:
Post a Comment